Sen. Marco Rubio, R-Fla., is once again introducing a bill that would exempt premium and traditional cigars from FDA regulation.
The Reagan-Udall Foundation’s report is critical of FDA’s leadership, transparency and inability to act quickly. While cigars are barely mentioned in the report, there are some parts of this that could impact the regulation of cigars in the future.
The report indicated that FDA issued warning letters to 899 online retailers from 2010-2020 but “took no enforcement actions.”
This is the latest in a long line of rulings against American regulators who have attempted to require more aggressive warning labels on tobacco products. Even if FDA had won the case, the ruling would have had no immediate impact on cigars.
PCA’s meeting comes while the industry awaits whether FDA will still regulate “premium cigars.”
Henney served as FDA Commissioner from 1999-2001.
Yesterday, the cigar industry and the Department of Justice submitted briefs regarding the outcome of a July 2022 ruling by a federal court in Washington, D.C. If the cigar industry is successful, “premium cigars” might be deregulated.
Manufacturers, retailers, consumers and other interested parties are invited to submit comments on the matter.
The Reagan-Udall Foundation will evaluate FDA’s actions in regards to JUUL’s botched PMTA process as well as the baby formula shotrage.
So you want to know what happens next. Here are “nine” “thoughts” on the matter.
The premium cigar industry’s nearly six-year lawsuit against the U.S. Food & Drug Administration received its biggest win to date. The stage is set for premium cigars to be exempt from FDA regulation.